Alpha Tau Medical (DRTS) Stock Forecast, Price Target & Predictions
DRTS Stock Forecast
Alpha Tau Medical stock forecast is as follows: an average price target of $7.00 (represents a 204.35% upside from DRTS’s last price of $2.30) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
DRTS Price Target
DRTS Analyst Ratings
Buy
Alpha Tau Medical Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 21, 2024 | Jason Bednar | Piper Sandler | $7.00 | $2.91 | 140.55% | 204.35% |
Nov 23, 2022 | - | Piper Sandler | $12.00 | $3.75 | 220.00% | 421.74% |
10
Alpha Tau Medical Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $7.00 |
Last Closing Price | $2.30 | $2.30 | $2.30 |
Upside/Downside | -100.00% | -100.00% | 204.35% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 11, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Aug 21, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Aug 15, 2024 | Piper Sandler | Overweight | Overweight | Hold |
May 21, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Nov 23, 2022 | Piper Sandler | Overweight | Overweight | Hold |
10
Alpha Tau Medical Financial Forecast
Alpha Tau Medical Revenue Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $20.68M | $14.48M | $5.80M | $5.60M | $3.70M | $2.20M | $533.33K | $466.67K | $200.00K | $100.00K | $150.00K | $62.50K | $30.00K |
High Forecast | $20.68M | $14.48M | $5.80M | $5.60M | $3.70M | $2.20M | $533.33K | $466.67K | $200.00K | $100.00K | $150.00K | $62.50K | $30.00K |
Low Forecast | $20.68M | $14.48M | $5.80M | $5.60M | $3.70M | $2.20M | $533.33K | $466.67K | $200.00K | $100.00K | $150.00K | $62.50K | $30.00K |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Alpha Tau Medical EBITDA Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Alpha Tau Medical Net Income Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $-9.08M | $-12.58M | $-9.08M | $-8.38M | $-8.38M | $-8.38M | $-9.78M | $-9.32M | $-8.38M | $-8.41M | $-8.97M | $-8.41M | $-8.04M |
High Forecast | $-9.08M | $-12.58M | $-9.08M | $-8.38M | $-8.38M | $-8.38M | $-9.78M | $-9.32M | $-8.38M | $-8.41M | $-8.97M | $-7.76M | $-8.04M |
Low Forecast | $-9.08M | $-12.58M | $-9.08M | $-8.38M | $-8.38M | $-8.38M | $-9.78M | $-9.32M | $-8.38M | $-8.41M | $-8.97M | $-9.05M | $-8.04M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Alpha Tau Medical SG&A Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Alpha Tau Medical EPS Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $-0.13 | $-0.18 | $-0.13 | $-0.12 | $-0.12 | $-0.12 | $-0.14 | $-0.13 | $-0.12 | $-0.12 | $-0.13 | $-0.12 | $-0.12 |
High Forecast | $-0.13 | $-0.18 | $-0.13 | $-0.12 | $-0.12 | $-0.12 | $-0.14 | $-0.13 | $-0.12 | $-0.12 | $-0.13 | $-0.11 | $-0.12 |
Low Forecast | $-0.13 | $-0.18 | $-0.13 | $-0.12 | $-0.12 | $-0.12 | $-0.14 | $-0.13 | $-0.12 | $-0.12 | $-0.13 | $-0.13 | $-0.12 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Alpha Tau Medical Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
INZY | Inozyme Pharma | $2.69 | $14.67 | 445.35% | Buy |
MOLN | Molecular Partners | $5.42 | $29.00 | 435.06% | Buy |
GNFT | Genfit | $4.24 | $13.00 | 206.60% | Buy |
DRTS | Alpha Tau Medical | $2.30 | $7.00 | 204.35% | Buy |
ELYM | Eliem Therapeutics | $5.11 | $13.00 | 154.40% | Buy |
OCUL | Ocular Therapeutix | $8.52 | $17.50 | 105.40% | Buy |
CYT | Cyteir Therapeutics | $3.02 | $2.00 | -33.77% | Sell |